Framework Journal · one stock, one dated entry

Recorded 2025-12-31 · Permanent

Quest Diagnostics DGX

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

The label
Markdown

read at $200.29

Quest Diagnostics holds its Markdown at $200.29.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markdown label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · does not pass the values gate

The investor read · the season, not the day

As held on the ledger · 2025-12-31
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 72 days
Price$200.29
Valuation20.70 trailing · 16.10 forward price to earnings
Values screenFAIL · score 10.0
Beta0.60

The trader read · the latest dated commentary

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Entered 2026-07-03 · Markdown

The dated journal · newest first, never edited

2026-07-03 Markdown $200.29 +0.0% Entry 2

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markdown $200.29 Entry 1

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The insider ledger · Form 4 filings, as filed

Most recent filings · DGX
DateInsiderTitleTypeSharesValue
2026-04-20 PLEWMAN PATRICK Officer 49 $9,540
2026-04-20 LASSITER WRIGHT III Director 6 $1,168
2026-04-20 KUPPUSAMY KARTHIK Officer 39 $7,593
2026-04-20 DELANEY MARK E Officer 37 $7,204
2026-04-20 GREGG VICKY B Director 68 $13,239
2026-04-20 SAMAD SAMER ABDUL Chief Financial Officer 108 $21,027
2026-03-09 WENTWORTH TIMOTHY CHARLES Director 215 ·
2026-03-05 PREVOZNIK MICHAEL E General Counsel 3,878 $799,682
2026-03-05 DOHERTY CATHERINE T Officer 5,558 $1,146,115
2026-03-05 PLEWMAN PATRICK Officer 2,855 $588,730

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $189.81 +7.0% · $1,070 +7.0%
2 months $191.51 +6.1% · $1,061 +6.1%
3 months $200.01 +1.6% $0.86 $1,020 +2.0%
6 months $179.96 +12.9% $1.66 $1,138 +13.8%
1 year $174.30 +16.5% $3.26 $1,184 +18.4%
2 years $136.20 +49.1% $6.31 $1,538 +53.8%
3 years $126.73 +60.3% $9.19 $1,675 +67.5%
5 years $115.43 +76.0% $14.40 $1,884 +88.4%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever DGX does next, these words stay.

Quest Diagnostics · DGX · Markdown · $200.29
Recorded 2025-12-31 · before the outcome · scored mechanically

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.